Stock Events

Stock Events

Guardant Health 

€74.48
142
+€2.85+3.98% Monday 06:03

Statistics

Day High
74.48
Day Low
74.48
52W High
99.34
52W Low
32.85
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.85
-0.78
-0.72
-0.65
Expected EPS
-0.68783234
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5GH.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.63B
Illumina provides genomic sequencing solutions and competes directly in the precision medicine space, offering technologies that overlap with Guardant Health's cancer detection and treatment monitoring services.
Fulgent Genetics
FLGT
Mkt Cap407.57M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics space with Guardant Health.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences offers sequencing systems that compete in the broader market of genomic analysis, including applications in cancer research and diagnostics.
Bionano Genomics
BNGO
Mkt Cap13.09M
Bionano Genomics provides tools for genomic analysis, including structural variant detection that can be applied in cancer research, competing in the genomics space.
Myriad Genetics
MYGN
Mkt Cap466.55M
Myriad Genetics offers genetic testing and precision medicine solutions, including for cancer, competing with Guardant Health in the personalized healthcare market.
Qiagen NV
QGEN
Mkt Cap7.06B
Qiagen provides sample and assay technologies for molecular diagnostics, including cancer, competing in the field of precision medicine and diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific offers a broad range of solutions for genetic analysis and diagnostics, including cancer, competing with Guardant Health in the life sciences and healthcare sectors.

About

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Show more...
CEO
Dr. Helmy Eltoukhy Ph.D.
Employees
1373
Country
United States
ISIN
US40131M1099

Listings

MI
IT
1GH.MI
STU
DE
5GH.STU
MU
DE
5GH.MU
MX
MX
GH.MX

0 Comments

Share your thoughts

FAQ

What is Guardant Health stock price today?▼
The current price of 5GH.MU is €74.48 EUR — it has increased by +3.98% in the past 24 hours. Watch Guardant Health stock price performance more closely on the chart.
What is Guardant Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Guardant Health stocks are traded under the ticker 5GH.MU.
Is Guardant Health stock price growing?▼
5GH.MU stock has fallen by -1.88% compared to the previous week, the month change is a -4.68% fall, over the last year Guardant Health has showed a +91.76% increase.
When is the next Guardant Health earnings date?▼
Guardant Health is going to release the next earnings report on May 07, 2026.
What were Guardant Health earnings last quarter?▼
5GH.MU earnings for the last quarter are -0.85 EUR per share, whereas the estimation was -0.65 EUR resulting in a -30.42% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Guardant Health have?▼
As of May 06, 2026, the company has 1,373 employees.
In which sector is Guardant Health located?▼
Guardant Health operates in the Health & Wellness sector.
When did Guardant Health complete a stock split?▼
Guardant Health has not had any recent stock splits.
Where is Guardant Health headquartered?▼
Guardant Health is headquartered in Redwood City, United States.